"With a partner and growing Roche demand alone (Roche had identified 8 targets for the substance) I say dividends could become a reality in 2021/2022. AIMO."
Any profit would be reinvested into R&D to prolong the go-it-alone strategy which has been in effect all the while King says "partner." It's the company mantra.